Stately Bio

Developer of machine learning cell imaging platform for regenerative medicines

placePalo Alto, California, United States calendar_todayFounded 2021 language statelybio.com

Innovation

1 patent family (1 granted) — focus: Physics & computing; filing pace active. Cited 40 times.

YearFilings
20241

Investor mix

11 investors on record; lead investors include AIX Ventures.

Investor typeCountShare
Venture capital873%
Other / undisclosed327%
Coming soon